Volume 24 - Issue 4 - April 2012
Column
Radial Access Technique
03/27/2012
Harsh Golwala, MD, Soni Zacharias, MD, Faisal Latif, MD
Harsh Golwala, MD, Soni Zacharias, MD...
Abstract: Patients in whom femoral arterial access is not feasible pose a challenge in terms of hemodynamic support during high-risk percutaneous coronary intervention. Patient’s height adds another challenge given the fixed lengths of...
Abstract: Patients in whom femoral arterial access is not feasible pose a challenge in terms of hemodynamic support during high-risk percutaneous coronary intervention. Patient’s height adds another challenge given the fixed lengths of...
Abstract: Patients in whom...
03/27/2012
Journal of Invasive Cardiology
Feature
Review
03/27/2012
Kiyotake Ishikawa, MD1,2, Yutaka Aoyama, MD1, Haruo Hirayama, MD, PhD1
Kiyotake Ishikawa, MD1,2, Yutaka Aoya...
Abstract: In-stent restenosis has been a longstanding problem after percutaneous coronary intervention. The introduction of the drug-eluting stent (DES) successfully reduced the rate of restenosis; however, it is not completely diminished....
Abstract: In-stent restenosis has been a longstanding problem after percutaneous coronary intervention. The introduction of the drug-eluting stent (DES) successfully reduced the rate of restenosis; however, it is not completely diminished....
Abstract: In-stent restenosis...
03/27/2012
Journal of Invasive Cardiology
Original Contribution
03/26/2012
Nick J. Collins, FRACP1, Rachael Hatton, FRACP1, Kevin Ng, FRACP2, Rohan Bhagwandeen, FRACP1, John Attia, PhD3, Chris Oldmeadow, PhD3, Rohan Jayasinghe, PhD2
Nick J. Collins, FRACP1, Rachael Hatt...
Abstract: Background. Percutaneous device closure is a therapeutic option in patients with presumed stroke complicating paradoxical emboli. Newer devices with lower profiles and potentially reduced thrombogenicity have emerged, such as the...
Abstract: Background. Percutaneous device closure is a therapeutic option in patients with presumed stroke complicating paradoxical emboli. Newer devices with lower profiles and potentially reduced thrombogenicity have emerged, such as the...
Abstract: Background....
03/26/2012
Journal of Invasive Cardiology
Original Contribution
03/26/2012
Shin Watanabe, MD1, Naritatsu Saito, MD1, Akihiro Tokushige, MD1, Bao Bingyuan, MD1, Yoshiaki Kawase, MD2, Takeshi Kimura, MD1
Shin Watanabe, MD1, Naritatsu Saito, ...
Abstract: Background. Although several types of distal embolic protection devices have been developed, they are usually difficult to use because of their stiff and bulky characteristics. We present a novel method to deliver the coronary...
Abstract: Background. Although several types of distal embolic protection devices have been developed, they are usually difficult to use because of their stiff and bulky characteristics. We present a novel method to deliver the coronary...
Abstract: Background. Although...
03/26/2012
Journal of Invasive Cardiology
Original Contribution
03/26/2012
Reza Arsanjani, MD, Avinash Khitri, MD, Mehrnoosh Hashemzadeh, PhD, Mohammad Reza Movahed, MD
Reza Arsanjani, MD, Avinash Khitri, M...
Abstract: Background. Full therapeutic heparin doses ranging from 5000-10,000 units or weight based (70-100 units/kg) have been recommended during percutaneous coronary interventions. However, there are currently no data available in regards...
Abstract: Background. Full therapeutic heparin doses ranging from 5000-10,000 units or weight based (70-100 units/kg) have been recommended during percutaneous coronary interventions. However, there are currently no data available in regards...
Abstract: Background. Full...
03/26/2012
Journal of Invasive Cardiology
Original Contribution
03/26/2012
Florim Cuculi, MD1, Mabelle Young, MD1, Remo Beeler, MD1, Andreas W. Schoenenberger, MD2, Paul Erne, MD1
Florim Cuculi, MD1, Mabelle Young, MD...
Abstract: Introduction. Drug-coated balloons (DCB) are being increasingly used in interventional cardiology and are established for the treatment of in-stent restenosis (ISR). It is unclear how effective they are in patients with de novo...
Abstract: Introduction. Drug-coated balloons (DCB) are being increasingly used in interventional cardiology and are established for the treatment of in-stent restenosis (ISR). It is unclear how effective they are in patients with de novo...
Abstract: Introduction....
03/26/2012
Journal of Invasive Cardiology
Original Contribution
03/26/2012
Michael R. Recto, MD1, Matthew Stohs1, Thomas Yeh Jr, MD, PhD2
Michael R. Recto, MD1, Matthew Stohs1...
Abstract: Background. The Amplatzer Vascular Plug (AVP) I and AVP II have been used successfully to occlude moderate-large venous collateral vessels (VC) and pulmonary arteriovenous malformations (PAVM) in children and adults with congenital...
Abstract: Background. The Amplatzer Vascular Plug (AVP) I and AVP II have been used successfully to occlude moderate-large venous collateral vessels (VC) and pulmonary arteriovenous malformations (PAVM) in children and adults with congenital...
Abstract: Background. The...
03/26/2012
Journal of Invasive Cardiology
03/26/2012
Michael Liang, MBChB, FRACP1,2, Gerard Devlin, FRACP1, Sanjeevan Pasupati, MBChB, FRACP1
Michael Liang, MBChB, FRACP1,2, Gerar...
Abstract: Background. Transcatheter aortic valve implantation (TAVI) has been performed at Waikato Hospital for high-risk severe symptomatic aortic stenosis patients who are considered unsuitable for conventional cardiac surgery for the last...
Abstract: Background. Transcatheter aortic valve implantation (TAVI) has been performed at Waikato Hospital for high-risk severe symptomatic aortic stenosis patients who are considered unsuitable for conventional cardiac surgery for the last...
Abstract: Background....
03/26/2012
Journal of Invasive Cardiology
03/26/2012
Raffi Bekeredjian, MD, Emmanuel Chorianopoulos, MD, Hugo A. Katus
Raffi Bekeredjian, MD, Emmanuel Chori...
Abstract: Transfemoral aortic valve implantation has become an important interventional technique for patients with severe aortic stenosis and high surgical risks. The mitral valve has been a much greater challenge for interventional...
Abstract: Transfemoral aortic valve implantation has become an important interventional technique for patients with severe aortic stenosis and high surgical risks. The mitral valve has been a much greater challenge for interventional...
Abstract: Transfemoral aortic...
03/26/2012
Journal of Invasive Cardiology
Insights
Commentary
03/26/2012
Herbert D. Aronow, MD, MPH
Herbert D. Aronow, MD, MPH
There has been tremendous evolution in drug and device therapy for percutaneous coronary intervention (PCI) since its inception more than 3 decades ago. Although direct thrombin inhibitors, and to a lesser extent low molecular weight heparin,...
There has been tremendous evolution in drug and device therapy for percutaneous coronary intervention (PCI) since its inception more than 3 decades ago. Although direct thrombin inhibitors, and to a lesser extent low molecular weight heparin,...
There has been tremendous...
03/26/2012
Journal of Invasive Cardiology
